Mata CD

Language: Spanish
References: 20
Page: 607-613
PDF size: 272.18 Kb.

ABSTRACT

Massive blood loss is considered an important cause of preventable mortality worldwide. It is associated with secondary coagulopathy, a decrease in tissue perfusion, and consumption of coagulation factor and platelets. There are two elemental concepts that should be distinguished: control damage surgery and resuscitation in hemostatic control; one emphasizes on provisional but early hemostatic control, while the other one seeks prompt control of coagulopathy. As part of the therapeutic management of massive blood loss, the resuscitation with hemostatic control peruses an immediate and sustained plasmatic and platelet reconstitution, as well as red blood cells. The reconstitution of these three components resembles the physiologic composition of blood, impedes hypovolemia and coagulopathy. Viscoelastic coagulation tests (such as ROTEM or TEG) have emerged as practical, rapid and sensitive diagnostic modalities. Their role in therapeutic targeting has demonstrated multiple benefits. Blood component transfusion should be based on the analytic results of these tests.

REFERENCES

1. Afshari A, Wikkels A, Brok J, Miller A, Wetterslev J. Tromboelastografía (TEG) o tromboelastometría (ROTEM) para monitorizar la hemoterapia versus la atención habitual en pacientes con una transfusión masiva (Revision Cochrane traducida). Cochrane Database of Systematic Reviews. 2011; Issue 3. Art. No.: CD007871.

2. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, Pittet JF. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. Journal of Trauma. 2008 May; 64(5):1211-7.

3. Dente CJ, Shaz BH, Nicholas JM, et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. Journal of Trauma. 2009; 66:1616–1624. [PubMed: 19509623].

4. Dutton RP. Current concepts in hemorrhagic shock. Anesthesiology Clin. 2007; 25:23 -34.

5. Egorinaa E, Sovershaeva M, Hansena JB. The role of tissue factor in systemic inflammatory response syndrome. Blood Coagul Fibrinolysis. 2011, 22:451–456.

6. Frith D, Davenport R, Brohi K. Acute traumatic coagulopathy. Curr Opin Anesthesiol. 2012, 25:229–234.

7. Godiera A, Samamaa CM, Susenb S. Plasma/platelets/red blood cell ratio in the management of the bleeding traumatized patient: does it matter? Curr Opin Anesthesiol. 2012, 25:242–247.

8. Ickxa B, Faraonib D. Management of the clotting system: a European perspective. Curr Opin Anesthesiol. 2012, 25:80–85.

9. Johansson PI, Ostrowski SR, Secher NH. Management of major blood loss: An update. Acta Anaesthesiologica Scandinavica. 2010; 54: 1039-1049.

10. Johansson P, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scandinavian Journal of Trauma. 2009;17:45.

11. Lelubre C, Vincent JL. Red blood cell transfusion in the critically ill patient. Annals of Intensive Care. 2011, 1:43.

12. Nunez TC, Voskresensky IV, Dossett LA, Shinall R, Dutton WD, Cotton BA. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption). Journal of Trauma and Acute Care Surgery. 2009; 66:346– 52. [PubMed: 19204506]

13. Raffán F, Gempeler F, Mejía JH. Control Avanzado del Sangrado en Trauma y Cirugía Mayor: Parte I. Edición 2da. Colombia, 2009.

14. Raymer J, Flynn L, Martin R. Massive Transfusion of Blood in the Surgical Patient. Surg Clin N Am. 2012;92:221- 234

15. Spinella PC, Holcomb JB. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev. 2009; 23:231–240. [PubMed: 19695750]

16. Stainsby D, MacLennan S, Thomas D. Guidelines on the management of massive blood loss. British Journal of Haematology. 2006, 135:634–641.

17. Van der Lindena P, De Hertb S. Red blood cell transfusion in the bleeding traumatized patient. Curr Opin Anesthesiol. 2012, 25:226–228.

18. Weiss G et al. Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register. Blood Coagulation and Fibrinolysis. 2011, 22:727–734.

19. Young P, Cotton B, Goodnough L. Massive transfusion protocols for patients with substantial hemorrhage. Transfus Med Rev. 2011;25(4):293-303.

20. Zunini G, Rando K, Martínez F, Castillo A. Transfusión masiva y manejo del paciente traumatizado: enfoque fisiopatológico del tratamiento. Cirugía y Cirujanos. 2011;79:473-480.